Real life management of community-acquired Pneumonia in adults in the Gulf region and comparison with practice guidelines: a prospective study

BMC Pulmonary Medicine

Rania El-Bishbishi¹  Michael S. Niederman²  Raees Ahmed⁵  Ola Mohamed Al Ali⁴  Ashraf Al Zaabi³  Bassam Mahboub⁴ 

[1] Department of Medical Affairs, Sanofi, Dubai, United Arab Emirates;Winthrop-University Hospital, Mineola, USA;Zayed Military Hospital, Abu Dhabi, United Arab Emirates;Rashid Hospital, Oud Metha Road, Umm Hurair Area 2, Dubai, UAE;Rashid Hospital Trauma Center, Dubai, United Arab Emirates

关键词: Gulf countries;    Guidelines;    Management;    Community-acquired pneumonia;   

Others  :  1228328
DOI  :  10.1186/s12890-015-0108-x

 received in 2015-01-30, accepted in 2015-09-23,  发布年份 2015

【 摘 要 】

Background

Very few data exist on the management of community-acquired pneumonia (CAP) in patients admitted to hospitals in the Gulf region. The objectives of this study were to describe treatment patterns for CAP in 38 hospitals in five Gulf countries (United Arab Emirates, Kuwait, Bahrain, Oman, and Qatar) and to compare the findings to the most recent Infectious Diseases Society of America (IDSA) / American Thoracic Society (ATS) guidelines.

Methods

This was a prospective, observational study conducted between January 2009 and February 2011. Adult patients hospitalised (excluding intensive care units) for CAP and subsequently discharged were included. Data were collected retrospectively at hospital discharge, and prospectively during two follow-up visits. Data on medical history, mortality-risk scores, diagnostic criteria, antibiotic treatment, isolated pathogens and clinical and radiographic outcomes were collected. Care practices were compared to the IDSA/ATS guidelines.

Results

A total of 684 patients were included. The majority (82.9 %) of patients were classified as low risk for mortality (pneumonia severity index II and III). The majority of patients fulfilled criteria for treatment success at discharge, although only 77.6 % presented a normalised leukocyte count. Overall, the management of CAP in Gulf countries is in line with the IDSA/ATS guidelines. This applied to the diagnosis of CAP, to the identification of high-risk CAP patients, to the identification of etiologic agent responsible for CAP and to the type of treatment despite the fact that combinations of antimicrobial agents were not consistent with the guidelines in 10 % of patients. In all patients, information about Gram’s staining was not captured as recommended by the IDSA/ATS and in the majority of patients (>85 %) chest radiography was not systematically performed at the post-discharge follow-up visits.

Discussion

The management of CAP in the Gulf region is globally in line with current IDSA/ATS guidelines, although rates of pathogen characterisation and post-discharge follow-up need to be improved.

Conclusion

Compliance with established guidelines should be encouraged in order to improve the management of the disease in this region.

【 授权许可】

   
2015 Mahboub et al.

【 参考文献 】

• [1]Wunderink RG, Waterer GW. Clinical practice. Community-acquired pneumonia. N Engl J Med. 2014; 370(6):543-551.
• [2]Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC et al.. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007; 44 Suppl 2:S27-S72.
• [3]Bernstein JM. Treatment of community-acquired pneumonia--IDSA guidelines. Infectious Diseases Society of America. Chest. 1999; 115(3 Suppl):9S-13S.
• [4]Niederman MS, Luna CM. Community-acquired pneumonia guidelines: a global perspective. Semin Respir Crit Care Med. 2012; 33(3):298-310.
• [5]McCabe C, Kirchner C, Zhang H, Daley J, Fisman DN. Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules. Arch Intern Med. 2009; 169(16):1525-1531.
• [6]Grenier C, Pepin J, Nault V, Howson J, Fournier X, Poirier MS et al.. Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia. J Antimicrob Chemother. 2011; 66(7):1617-1624.
• [7]Watkins RR, Lemonovich TL. Diagnosis and management of community-acquired pneumonia in adults. Am Fam Physician. 2011; 83(11):1299-1306.
• [8]Arnold FW, LaJoie AS, Brock GN, Peyrani P, Rello J, Menendez R et al.. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results. Arch Intern Med. 2009; 169(16):1515-1524.
• [9]Ramirez J. Multicenter, multinational observational studies: a new approach to studying community-acquired pneumonia. Respir Care Clin N Am. 2005; 11(1):35-44.
• [10]Fahimi F, Moradi M, Safarnavadeh T, Namdar R. Management of Community Acquired Pneumonia in a Teaching Hospital: The Role of Established Guidelines. Tanaffos. 2007; 6(2):32-37.
• [11]Al-Abri SS, Al-Maashani S, Memish ZA, Beeching NJ. An audit of inpatient management of community-acquired pneumonia in Oman: a comparison with regional clinical guidelines. J Infect Public Health. 2012; 5(3):250-256.
• [12]Memish ZA, Arabi YM, Ahmed QA, Shibl AM, Niederman MS. Management and prevention strategies for community-acquired pneumonia in the Gulf Corporation Council. J Chemother. 2007; 19 Suppl 1:33-46.
• [13]Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE et al.. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997; 336(4):243-250.
• [14]Etzion O, Novack V, Avnon L, Porath A, Dagan E, Riesenberg K et al.. Characteristics of low-risk patients hospitalized with community-acquired pneumonia. Eur J Intern Med. 2007; 18(3):209-214.
• [15]Andrews EA, Avorn J, Bortnichak EA, Chen R, Dai WS, Dieck GS et al.. Guidelines for Good Epidemiology Practices for drug, device, and vaccine research in the United States. Pharmacoepidemiol Drug Saf. 1996; 5(5):333-338.
• [16]Patterson CM, Loebinger MR. Community acquired pneumonia: assessment and treatment. Clin Med. 2012; 12(3):283-286.
• [17]Rossio R, Franchi C, Ardoino I, Djade CD, Tettamanti M, Pasina L, et al. Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia. Eur J Intern Med. 2015.
• [18]Lim WS, Macfarlane JT, Boswell TC, Harrison TG, Rose D, Leinonen M et al.. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax. 2001; 56(4):296-301.
• [19]Ewig S, Torres A, Woodhead M. Assessment of pneumonia severity: a European perspective. Eur Respir J. 2006; 27(1):6-8.
• [20]Blasi F, Garau J, Medina J, Avila M, McBride K, Ostermann H et al.. Current management of patients hospitalized with community-acquired pneumonia across Europe: outcomes from REACH. Respir Res. 2013; 14:44. BioMed Central Full Text
• [21]Population Division. 2015.